Rapamycin and malignant neoplasm progression Patient Reports February 12, 2012
Rapamycin Side Effects Report #4647368-9
Rapamycin side effect was reported by a Health Professional from on Apr 27, 2005. Male patient was diagnosed with pancreatic carcinoma and was treated with Rapamycin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma. Rapamycin dosage: 500MG QD ORAL. Patient died on 03/30/2005.
Rapamycin Side Effects Report #5060749-7
Rapamycin side effect was reported by a Health Professional from UNITED STATES on July 21, 2006. Male patient, weighting 222.7 lb, was treated with Rapamycin. After drug was administered, patient experienced the following side effects: ascites, hepatic neoplasm malignant, malignant neoplasm progression, pain
. Rapamycin dosage: unknown. Patient was hospitalized. Patient recovered.
Rapamycin and malignant neoplasm progression 